Doylestown Hospital, in conjunction with MIT (Molecular Imaging Technologies) PET, operates a full-time, fixed 16-slice PET/CT scanner. This state-of-the-art equipment allows physicians to more effectively diagnose, stage, and monitor therapy for a variety of cancers and to diagnose multiple neurological and cardiac diseases.
The PET/CT Center at Doylestown Hospital is a suite of well-appointed rooms specifically designed to provide comfort and convenience for PET/CT patients. The PET/CT center is an accredited facility through the American College of Radiology. Also available are a full range of ancillary services, from expert assistance with insurance claims to complimentary valet parking.
PET/CT interpretations are performed by Doylestown Hospital's board-certified radiologists, including the program's director, Mark Silidker, MD, who has extensive expertise in PET/CT interpretations. He believes, "the tremendous impact PET/CT has the ability to combine the anatomic strength of CT with the physiologic changes detected by PET. This often facilitates in earlier detection of cancers" adds Mitchell Alden, DO, the Director of the Cancer Program at Doylestown Hospital, "PET/CT is the most sensitive tool available. Combining 2 imaging technologies, PET/CT allows oncologists to precisely pinpoint sites of cancer within the body. When this information is used in radiation therapy treatment planning, it enables the sparing of normal tissue.